Cargando…

Su089 SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IBS DURING COVID-19: INITIAL FINDINGS FROM A CROSS-SECTIONAL SURVEY

Detalles Bibliográficos
Autores principales:	Yu, Christine, Tovar, Stephanie, Padilla, Ariadna, Pounds, Dana, Shi, Jiaxiao M., Wu, Bechien U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108163/ http://dx.doi.org/10.1016/S0016-5085(21)02165-X

Ejemplares similares

Satisfaction With Telehealth Among Patients With Irritable Bowel Syndrome During COVID-19: Cross-Sectional Survey Findings
por: Yu, Christine, et al.
Publicado: (2022)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Su1000: IMPACT OF COVID-19 PANDEMIC AND SOCIAL DETERMINANTS OF HEALTH ON UTILIZATION OF TELEHEALTH SERVICES
por: Sanaka, Harsha, et al.
Publicado: (2022)

Su1005: PRE-ENDOSCOPY CONSULTATION AND ADHERENCE TO OUTPATIENT ENDOSCOPY DURING COVID-19 PANDEMIC: IN-PERSON VISIT VERSUS TELEHEALTH
por: Musa, Abdullahi, et al.
Publicado: (2022)

Fr010 THE DIFFERENTIAL IMPACT OF COVID-19 ON GASTROINTESTINAL ILLNESSES AND RATES OF HOSPITALIZATION: ANALYSIS FROM A REGIONAL INTEGRATED HEALTHCARE SYSTEM
por: Tran, Tri M., et al.
Publicado: (2021)

Fr502 INFLAMMATORY BOWEL DISEASE AND COVID-19: A LARGE INTEGRATED HEALTHCARE EXPERIENCE
por: Tashjian, Vartan C., et al.
Publicado: (2021)

Su1487: IMPACT OF INFLAMMATORY BOWEL DISEASE THERAPIES ON DURABILITY OF HUMORAL RESPONSE TO SARS COV-2 VACCINATION
por: Charilaou, Paris, et al.
Publicado: (2022)

Fr014 DISEASE BURDEN AND CARE-SEEKING BEHAVIOR FOR IBS-C PATIENTS IN THE UNITED STATES IN THE ERA OF COVID-19
por: Lacy, Brian E., et al.
Publicado: (2021)

Mo1019: THE IMPACT OF IBS ON SELF-REPORTED PHYSICAL AND MENTAL HEALTH DURING THE COVID PANDEMIC – A NORWEGIAN TWIN STUDY
por: Kutschke, Julia, et al.
Publicado: (2022)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Su1270: CHRONIC PANCREATITIS AND COVID-19: INCIDENCE AND OUTCOMES. A MULTICENTER RESEARCH NETWORK ANALYSIS
por: Hadi, Yousaf, et al.
Publicado: (2022)

Su1094: HOSPITILISATIONS FOR NOROVIRUS DECREASE DURING THE COVID-19 PANDEMIC
por: Gottlieb, Max T., et al.
Publicado: (2022)

Su1071: PREVALENCE OF GASTROINTESTINAL SYMPTOMS AND RELATIONSHIP WITH POOR OUTCOMES AMONG PATIENTS WITH COVID-19 PRESENTING TO THE HOSPITAL: A NATIONAL DATABASE STUDY
por: Patil, Nikita, et al.
Publicado: (2022)

Su094 IMMUNE AND METABOLIC PATHOGENESIS OF ENVIRONMENTAL ENTERIC DYSFUNCTION IN CHILDHOOD UNDERNUTRITION: A BIRTH INCEPTION COHORT
por: Haberman, Yael, et al.
Publicado: (2021)

Su1076: DIVERTICULOSIS IS ASSOCIATED WITH INTERNAL HEMORRHOIDS ON COLONOSCOPY: POSSIBLE CLUES TO ETIOLOGY.
por: Sninsky, Jared A., et al.
Publicado: (2022)

Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS
por: Blackett, John W., et al.
Publicado: (2021)

Su1495: COVID-19 VACCINE HESITANCY REMAINS HIGH IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Kwon, Hyuk Joon, et al.
Publicado: (2022)

Su1491: ATTITUDES AND PREDICTORS OF COVID-19 VACCINE UPTAKE IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
por: Vuitton, Lucine, et al.
Publicado: (2022)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Su1500: COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
por: Dubinsky, Marla C., et al.
Publicado: (2022)

Su1003: IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE ACCESS, DELIVERY AND VACCINATION IN PATIENTS WITH DIGESTIVE DISORDERS
por: Russin, Michelle, et al.
Publicado: (2022)

Sa1051: UTILIZATION OF A MULTIDISCIPLINARY TELEHEALTH MODEL TO IMPROVE ACCESS TO CARE AND MAINTAIN AN ACADEMIC TEACHING PARADIGM FOR A UNIQUE PATIENT POPULATION DURING THE COVID-19 PANDEMIC
por: Reddy, Kavya, et al.
Publicado: (2022)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Su1067: LIVER ENZYMES ALTERATION BUT NOT GI SYMPTOMS ARE ASSOCIATED WITH DEATH IN MINORITY COVID-19 PATIENTS WITH CANCER
por: Oskrochi, Gholamreza, et al.
Publicado: (2022)

Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES
por: Deepak, Parakkal, et al.
Publicado: (2022)

Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2021)

Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Schell, Trevor, et al.
Publicado: (2022)

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY
por: Geldof, Jeroen, et al.
Publicado: (2022)

Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Su1065: INCREASED INTEREST IN WEIGHT LOSS AND BARIATRIC INTERVENTIONS DURING THE COVID-19 PANDEMIC: AN ANALYSIS OF INTERNET SEARCH QUERIES
por: Rajan, Anjana, et al.
Publicado: (2022)

Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
por: Lelong, Margaux, et al.
Publicado: (2022)

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
por: Olayinka, Lily, et al.
Publicado: (2021)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

Su254 REDUCED ENDOSCOPY UTILIZATION FOR UPPER GASTROINTESTINAL BLEEDING DURING COVID-19 PANDEMIC: A MULTICENTER RESEARCH NETWORK STUDY
por: Goyal, Hemant, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fhmgt5t9agnerq98a2dg2jnn3m